Ledger.Open graph →
SEC Form D · filed September 10, 2019

CollPlant Biotechnologies Ltd

Offering
$3.5M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Other Health Care
Location
REHOVOT, L3
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Daniel Ward · SANTA MONICA, CAExecYoung N. Sohn · San Francisco, CAExecJohn Gallagher · San Antonio, TXDirectorSteven Crowe · SANTA MONICA, CAExecLip-Bu N. Tan · San Francisco, CADirectorJames B. Walters · Dallas, TXExecLuka Salamunic San Martin · Palo Alto, CAExecEd Byrne · San Antonio, TXDirectorLew Moorman · San Antonio, TXDirectorAdi Goldin · Caesarea, L3DirectorScott Burrell · Ness-Ziona, L3DirectorAlexander Magaro · Stamford, CTExecMichael Weiss · Stamford, CTExecJarrett Mcgovern · Stamford, CTExecGrant Gyesky · Stamford, CTExecMichael J. Giarla · Rocky Hill, CTExecTimothy M. Clorite · Clinton, CTDirectorDamian Duplessis · LOS ANGELES, CADirectorRajesh Mashruwala · PALO ALTO, CADirectorSeneca Management, LLC · Denver, CODirectorAdi Goldin · Ness-Ziona, L3DirectorWolfgang Ruttenstorfer · Rehovot, L3DirectorScott Burrell · Ness-Ziona, L3Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗